Coronary artery calcification in middle-aged women with premature ovarian insufficiency
Gunning, Marlise N.; Meun, Cindy; van Rijn, Bas B.; Maas, Angela H.E.M.; Benschop, Laura; Franx, Arie; Boersma, Eric; Budde, Ricardo P.J.; Appelman, Yolande; Lambalk, Cornelis B.; Eijkemans, Rene; Velthuis, Birgitta K.; Laven, Joop S.E.; Fauser, Bart C.J.M.; Baart, Sara; Brouwers, Laura; Cannegieter, Suzanne; Dam, Veerle; Daan, Nadine; Eijkemans, Rene; Ferrari, Michel; de Groot, Christianne; Hoek, Annemieke; Koffijberg, Erik; Koster, Wendy; Kruit, Mark; Lagerweij, Giske; Lambalk, Nils; Linstra, Katie; van der Lugt, Aad; van den Brink, Antoinette Maassen; Middeldorp, Saskia; Moons, Karel; van Lennep, Jeanine Roeters; Roos-Hesselink, Jolien; Scheres, Luuk; van der Schouw, Yvonne; Steegers, Eric; Steegers, Regine; Terwindt, Gisela; Wermer, Marieke; Zick, Bart; Zoet, Gerbrand; On behalf of the CREW-consortium
(2019) Clinical Endocrinology, volume 91, issue 2, pp. 314 - 322
(Article)
Abstract
Objective: Women with premature ovarian insufficiency (POI) enter menopause before age 40. Early menopause was associated with increased risk for coronary artery disease (CAD), death from cardiovascular disease and all-cause mortality. We compared the prevalence of CAD between middle-aged women on average 10 years following the initial POI diagnosis, with a
... read more
population-based cohort. Design: Cross-sectional case-control study. Participants: Women from two Dutch University Medical Centers above 45 years of age previously diagnosed with POI (n = 98) were selected and compared with age- and race-matched controls from the Multi-Ethnic Study of Atherosclerosis (MESA). Measurements: The primary outcome was detectable coronary artery calcium (CAC) determined by coronary computed tomography (CCT). Results: Women with POI had significantly higher blood pressure, cholesterol and glucose, despite lower BMI compared to controls. Similar proportions of detectable CAC (CAC score >0 Agatston Units) were observed in women with POI and controls (POI n = 16 (16%), controls n = 52 (18%), P = 0.40 and Padj = 0.93). In women with POI separately, we were not able to identify associations between CVD risk factors and CAC. The following CVD risk factors in controls were positively associated with CAC: age, diabetes mellitus, hypertension and LDL cholesterol. HRT use was negatively associated with CAC in controls. Conclusions: The presence of CAC did not differ significantly in women with POI around 50 years of age, compared to an age- and race-matched control group. We observe no increased calcified coronary disease in POI patients, despite the presence of unfavourable cardiovascular risk factors in these women.
show less
Download/Full Text
The full text of this publication is not available.
Keywords: cardiovascular, coronary artery calcium score, menopause, POI, reproductive disorder, risk factor, Humans, Middle Aged, Case-Control Studies, Calcinosis/complications, Female, Aged, Coronary Vessels/pathology, Primary Ovarian Insufficiency/complications, Endocrinology, Endocrinology, Diabetes and Metabolism, Journal Article, Research Support, Non-U.S. Gov't
ISSN: 0300-0664
Publisher: Wiley-Blackwell
Note: Funding Information: The CREW‐IMAGO study is funded by the Dutch Heart Foundation (Grant number 2013 T083). The Dutch Heart Foundation had no role in study design and is neither involved in collection, analysis and interpretation of data nor in writing the manuscript. Funding Information: The current study was funded by the Dutch Heart Foundation, grant number 2013T083 (MNG, CM, LB). AF received fees and grant sup‐ port from the following organizations (in alphabetic order): Dutch Heart Foundation (Hartstichting), Dutch Medical Research Counsel (ZonMW), Ferring, Leading the Change, Danone. BCJMF has re‐ ceived fees and grant support from the following organizations (in alphabetic order): Abbott, Controversies in Obstetrics & Gynecology (COGI), Dutch Heart Foundation (Hartstichting), Dutch Medical Research Counsel (ZonMW), Ferring, London Womens Clinic (LWC), Menogenix, Myovant, OvaScience, Pantarhei Bioscience, PregLem/ Gedeon Richter, Reproductive Biomedicine Online (RBMO), Teva/ Theramex, World Health Organization (WHO). JSEL has received fees and grant support from the following organizations (in alpha‐ betic order): Danone, Dutch Heart Foundation, Euroscreen, Ferring, Roche, Titus Healthcare and ZonMW. CBL has over the most recent 5‐year period received fees and grant support from the following or‐ ganizations (in alphabetic order): Amsterdam UMC, Ferring, Merck and ZonMW. AHEMM, BKV, EB, RPJB, YA, MJCE and BBR have nothing to disclose. Authors declare complete independence from funders. Funding Information: Funding information The CREW-IMAGO study is funded by the Dutch Heart Foundation (Grant number 2013 T083). The Dutch Heart Foundation had no role in study design and is neither involved in collection, analysis and interpretation of data nor in writing the manuscript. Hereby, we would like to thank the CREW consortium for their effort in the Cardiovascular Risk Profile: Imaging and Gender-Specific Disorders. We thank Dr. G.A. Zoet in particular for his pioneering work for the CREW consortium. Publisher Copyright: © 2019 John Wiley & Sons Ltd
(Peer reviewed)